期刊文献+

TGF-β1基因修饰的树突状细胞对实验性自身免疫性重症肌无力大鼠外周血单个核细胞CD28/CTLA-4:B7表达的影响 被引量:1

Effect of TGF-β1 gene-modified dendritic cells on expressions of CD28/CTLA-4:B7 in peripheral blood mononuclear cells in rats with experimental autoimmune myasthenia gravis
原文传递
导出
摘要 目的探讨TGF-β1基因修饰的树突状细胞(DC)对实验性自身免疫性重症肌无力(EAMG)大鼠外周血单个核细胞(PBMC)CD28/CTLA-4:B7表达的影响。方法近交系8~10周龄健康雌性Lewis大鼠30只.分为正常组、EAMG组、DC对照组、pcDNA3-TGF-β1-DC组、pcDNA3-DC对照组、生理盐水对照组。除正常组外.其余各组均采用丁氏双鳍电鳐电器官乙酰胆碱受体(AChR)蛋白二次免疫的方法复制EAMG大鼠模型。初次免疫后第5天分别皮下注射2×10^6的DC、pcDNA3-TGF-β1-DC、pcDNA3-DC及等体积的生理盐水,正常组和EAMG组不接受任何治疗。初次免疫后7周分离各组PBMC,应用RT-PCR和流式细胞术方法分别进行CD28、CTLA-4mRNA及B7-1、B7-2蛋白表达水平的检测。结果(1)正常组大鼠PBMCCD28、CTLA-4mRNA的表达水平较低,尤其CTLA-4mRNA极少量表达:EAMG组大鼠CD28、CTLA-4mRNA的表达水平均明显增加;pcDNA3-TGF-β1-DC组CD28mRNA的表达较EAMG组明显降低(氏0.01),而CTLA-4mRNA的表达水平较EAMG组明显增加(P〈0.05);EAMG组、DC治疗组、pcDNA3-DC对照组和生理盐水对照组之间CD28、CTLA-4mRNA的表达水平无显著性差异(胗0.05)。(2)正常大鼠B7-1、B7.2在PBMC上少量表达;EAMG组B7-1、B7-2两者表达明显增加(P〈0.001);pcDNA3.TGF-β1-DC治疗组B7-1、B7-2的表达较EAMG组均明显降低(P〈0.011;DC对照组、pcDNA3-DC对照组、生理盐水对照组与EAMG组比较均无明显差异(P〉0.05)。结论EAMG大鼠存在PBMCCD28/CTLA-4:B7协同刺激分子的表达异常,主动调节机体的共刺激通路可能是TGF-β1基因修饰的DC治疗EAMG的机制之一。 Objective To explore the effect of dendritic cells (DC) modified with transforming growth factor β1 (TGF-β1) gene on the expressions of CD28/CTLA-4:B7 costimulatory molecules in peripheral blood mononuclear cells (PBMC) in the Lewis rats with experimental autoimmune myasthenia gravis (EAMG). Methods Thirty inbreeding line, healthy, female Lewis rats were divided randomly into 6 groups: normal group, EAMG group, DC treatment group, pcDNA3-TGF-β1-DC treatment group, pcDNA3-DC control group and normal saline group. The rats were immunized with the AChR protein extracted from electric organ of Narcine timilei and CFA in the groups except normal group. 2x106 pcDNA3-TGF-β1-DCs/rat were injected subcutaneously into the backs of the rats which had been immunized 5 d earlier with AChR+CFA. The rats in DC treatment group, pcDNA3-DC control group and normal saline group were injected in parallel with untreated DC, pcDNA3-DC and normal saline, respectively. Seven weeks after the first immunization, the expressions of CD28 mRNA and CTLA-4 mRNA were detected by reverse transcription-polymerase chain reaction (RT-PCR), and the levels of B7-1 and B7-2 on the surface of PBMC were examined using flow cytometry. Results (1) The low expression of CD28 mRNA and rare expression of CTLA-4 mRNA were found in the normal rats, and both expressions increased markedly in EAMG rats (P〈0.001). Compared to those in EAMG group, the expression of CD28 mRNA decreased and CTLA-4 mRNA was upregulated after the treatment with pcDNA3-TGF-β1-DC (/9〈0.05). There was no significant difference in the expressions of CD28 mRNA and CTLA-4 mRNA among the EAMG group, DC treatment group, pcDNA3-DC control group and normal saline group (P〉0.05). (2) The expressions of CD28, CTLA-4, B7-1 and B7-2 on the surface of PBMC were rare in normal rats, which increased significantly in EAMG rats (P〈0.001). The levels of CD28, BT-1 and B7-2 in pcDNA3-TGF-β1-DC group were lower than those in EAMG group (P〈0.01), but the level of CTLA-4 was higher than that in EAMG group (P〈0.05). They showed no statistically difference among the EAMG group, DC treatment group, pcDNA3-DC control group and normal saline group (P〉0.05). Conclusions The expressions of CD28/CTLA-4:B7 costimulatory molecules are abnormal in the rats with EAMG. The regulation of CD28/CTLA-4:B7 costimulatory pathways may play a critical role in the mechanism of the treatment with DC transfected with pcDNA3-TGF-β1 in the incipient EAMG rats.
出处 《中华神经医学杂志》 CAS CSCD 2008年第5期474-478,共5页 Chinese Journal of Neuromedicine
基金 湖北省教育厅科学研究项目(20042001) 湖北省自然科学研究基金(2006BA344)
关键词 重症肌无力 树突状细胞 转化生长因子 CD28/CTLA-4:B7 Myasthenia gravis Dendritic cell Transforming growth factor-β1 CD28/CTLA-4:B7
  • 相关文献

参考文献13

  • 1Yarilin D, Duan R, Huang YM, et al. Dendritic cells exposed in vitro to TGF-betal ameliorate experimental autoimmune myasthenia gravis[J]. Clin Exp Immunol, 2002, 127(2): 214-219.
  • 2Xu L, Villain M, Galin Set al. Prevention and reversal of experimental autoimmune myasthenia gravis by a monoclonal antibody against acetycholine receptor-specific T cells [J]. Cellular Immunology, 2001, 208(2): 107-114.
  • 3Sperling AI. ICOS costimulation: is it the key to selective immunotherapy[J]. Clin Immunol, 2001, 100(3): 261-262.
  • 4Vermeiren J, Ceuppens JL, Haegel-Kronenberger H, et al. Blocking B7 and CD40 costimulatory molecules decreases antiviral T cell activity[J]. Clin Exp Immunol, 2004, 135(2): 253-258.
  • 5Inaba K, Inaba M, Romani N, et al. Generation of large number of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor [J]. J Exp Med, 1992, 176(6)- 1693-1702.
  • 6王云甫,孙圣刚,曹学兵,胡芳,陈吉相,俞善纯,何晓阔,尤春景.实验性重症肌无力大鼠模型的研究[J].中国神经免疫学和神经病学杂志,2003,10(4):242-245. 被引量:18
  • 7Sambrook J, Fritseh E F, Maniatis T(金冬雁,黎孟枫等译).分子克隆实验指南[M].第2版.北京:科学技术出版社,1993:672-690.
  • 8Perkins DL. T-cell activation in autoimmune and inflammatory diseases[J]. Curr Opin Nephrol Hypertens, 1998, 7(3): 297-303.
  • 9Zoller M. Costimulatory molecules and their ligands as therapeutic targets in autoimmune disease[J]. Eur J Dermatol, 2001, 11 (4): 335-342.
  • 10闫晓彩.免疫突触——共刺激作用机制研究进展[J].国外医学(免疫学分册),2001,24(2):100-102. 被引量:2

二级参考文献20

  • 1肖保国,乔健,吕传真.异种AchR检测抗AchR抗体的评价[J].上海免疫学杂志,1989,9(2):99-101. 被引量:1
  • 2李涛,姜健鹏.刺激及其操作条件对电刺激单纤维肌电图的影响[J].中华物理医学杂志,1995,17(2):68-70. 被引量:7
  • 3陈平,徐文桢,龚其美,李婉宜,周鸣生,袁必文.重症肌无力血清sIL-2R和AchR-ab水平变化的研究[J].上海免疫学杂志,1995,15(3):138-140. 被引量:13
  • 4彭秀玲 袁汉英 谢毅 等.基因工程实验技术: 2版[M].长沙:湖南科学技术出版社,1998.256-261.
  • 5徐浩鹏 孙曼霁 周廷冲.丁氏双鳍电鳐电器官烟碱样乙酰胆碱受体的分离提纯[J].Acta Biochinica et Biophysica Sinica(生物化学与生物物理学报:英文版),1984,16(1):50-55.
  • 6Christadoss P,Poussin M,Deng C.Animal models of myasthenia gravis[J].Clin Immunol,2000,94(2):75—87.
  • 7Lennon VA, Lindstrom JM, Seybold ME. Experimental autoimmune myasthenia: a model of myasthenia gravis in rats and guinea pigs[J]. J Exp Med,1975,141 (6) : 1365-1375.
  • 8Eldefrawi ME, Eldefrawi AT. Purification and molecular properties of the acetylcholine receptor from Torpedo electroplax [J]. Arch Biochem Biophys, 1973,159(1) :362-373.
  • 9Letterio JJ, Roberts AB. Regulation of immune responses by TGF-β. Annu Rev Immunol, 1998, 16:137-161.
  • 10Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature, 1998,392:245-252.

共引文献25

同被引文献6

  • 1Jonuleit H,Adema G,Schmitt E.Dendritic cells:specialized and regulated antigen processing machines[J].Gin Invest,2001,106(3):255-258.
  • 2Chapuis F,Rosenzwajg M,Yagello M,et al.Differentiation of human dendritic cells from monocytes in vitro[J].Eur J Immunol,1997,27(2):431-441.
  • 3Akagawa K S,Takasuka N,Nozki Y,et al.Generation of CD1 + Re1B + dendritic cells and tartrate-resistant acid phosphate-positive osteoclast-like multinucleated giant cells from human monocytes[J].Blood,1996,88(10):4029-4039.
  • 4Um H D,Cho Y H,Kim D K,et al.TNF-alpha suppresses dendritic cell death and the production of reactive oxygen intermediates induced by plasma withdrawal[J].Exp Dermatol,2004,13(5):282-288.
  • 5王新帅,赵勇刚,冯笑山,赵新汉,祁岩超,郭艳珍.负载U251抗原树突状细胞增强CIK杀伤作用的实验研究[J].中华神经医学杂志,2009,8(7):666-669. 被引量:4
  • 6范国昌,王福生,吴祖泽.树突状细胞疫苗的制备及其临床应用研究[J].国外医学(肿瘤学分册),2000,27(2):97-100. 被引量:8

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部